PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30292833-0	2019	Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasome.	Nicotinamide Mononucleotide	0-27	NLR family, pyrin domain containing 3	Rattus norvegicus	90-95	
30292833-9	2019	However, NMN treatment significantly alleviated Al-induced bone injuries by decreasing bone loss, suppressing oxidative stress as well as inhibiting Thioredoxin-interacting protein (TXNIP)-NLRP3 inflammasome pathway and pro-inflammatory cytokine production in vivo and in vitro.	Nicotinamide Mononucleotide	9-12	NLR family, pyrin domain containing 3	Rattus norvegicus	189-194	
30292833-11	2019	Collectively, our results suggest that NMN may reduce Al-induced bone loss partly by suppression of the TXNIP-NLRP3 inflammasome pathway.	Nicotinamide Mononucleotide	39-42	NLR family, pyrin domain containing 3	Rattus norvegicus	110-115